Document Detail


Antimicrobial peptides in periodontal innate defense.
MedLine Citation:
PMID:  22142958     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of oral biofilms and the host response to biofilm bacteria and their toxins are important factors in the development of periodontal disease. An early component of the host response is the secretion of antimicrobial proteins and peptides (AMPs) by salivary glands, oral epithelial cells and neutrophils. Over 45 AMPs have been identified in the oral cavity. All are found in saliva and several are also present in gingival crevicular fluid. Of these, 13 are up regulated in periodontal disease while 11 are downregulated. However, the concentrations of most AMPs found in oral fluids are below the effective in vitro concentrations, suggesting that local concentrations must be higher for effect or that additional biological functions are important in the oral cavity. Thus, in addition to direct antibacterial activity (e.g. bactericidal activity, bacterial agglutination), AMPs may affect the course of periodontal disease by inactivating bacterial or host proteases (e.g. secretory leukoprotease inhibitor) or bind bacterial toxins, including lipopolysaccharides (e.g. LL-37). Several AMPs (e.g. defensins) also act as immune system alarmins, i.e. endogenous mediators that recruit and activate antigen-presenting cells to enhance innate and adaptive immune responses. The differential regulation of AMP expression in periodontal disease suggests that AMP panels, including up- and downregulated proteins, can be used in oral fluid diagnosis of periodontal disease and to monitor treatment outcome.
Authors:
Sven-Ulrik Gorr
Related Documents :
17444278 - Iron homeostasis in chronic inflammation.
22033148 - Iron metabolism and the innate immune response to infection.
14596668 - A role for acidophilic granulocytes in the testis of the gilthead seabream (sparus aura...
11641968 - Evidence for a pro-apoptotic function of cd137 in granulocytes.
20956338 - Cutting edge: a critical functional role for il-23 in psoriasis.
19064698 - Induction of inflammatory and immune responses by hmgb1-nucleosome complexes: implicati...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2011-11-11
Journal Detail:
Title:  Frontiers of oral biology     Volume:  15     ISSN:  1420-2433     ISO Abbreviation:  Front Oral Biol     Publication Date:  2012  
Date Detail:
Created Date:  2011-12-06     Completed Date:  2012-01-10     Revised Date:  2012-04-13    
Medline Journal Info:
Nlm Unique ID:  9812095     Medline TA:  Front Oral Biol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  84-98     Citation Subset:  D; IM    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Affiliation:
Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, USA. surgorr@umn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigen-Presenting Cells
Antimicrobial Cationic Peptides / biosynthesis,  physiology*
Bacterial Toxins / metabolism
Biofilms
Biological Markers
Epithelial Cells / metabolism
Gene Expression Profiling
Gingival Crevicular Fluid / chemistry
Humans
Immunity, Innate*
Mouth Mucosa / cytology
Neutrophils / metabolism
Periodontal Diseases / immunology*,  microbiology*
Proteinase Inhibitory Proteins, Secretory / physiology
Salivary Proteins and Peptides / physiology*
Grant Support
ID/Acronym/Agency:
1R01 DE017989/DE/NIDCR NIH HHS; 2R01 DE012205/DE/NIDCR NIH HHS; R01 DE017989-03/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/Antimicrobial Cationic Peptides; 0/BPIFA2 protein, human; 0/Bacterial Toxins; 0/Biological Markers; 0/Proteinase Inhibitory Proteins, Secretory; 0/Salivary Proteins and Peptides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neutrophils in periodontal inflammation.
Next Document:  Modern approaches to non-surgical biofilm management.